Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04458246
Other study ID # 31314220.5.0000.0068
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 2020
Est. completion date June 2021

Study information

Verified date July 2020
Source University of Sao Paulo
Contact Bruno Gualano, PhD
Phone +55 11 3061-8789
Email gualano@usp.br
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Data show that the coronavirus disease 2019 (COVID-19) symptoms can be severe in 4% and 3% of the adolescents aged 11-15 years and ≥ 16 years, respectively. In addition, the prevalence of chronic diseases among adolescents has increased in the last years. About 20% of the adolescents have some chronic disease, resulting in increased morbidity and mortality. In march, 2020, the quarantine was officially implemented in Sao Paulo, while elective medical appointments for adolescents with chronic disease were temporarily suspended. To mitigate the deleterious effect of the social isolation on physical and mental health among these patients, this study aims to test the effects of an online, home-based, exercise training program.


Recruitment information / eligibility

Status Recruiting
Enrollment 140
Est. completion date June 2021
Est. primary completion date December 2020
Accepts healthy volunteers No
Gender All
Age group 10 Years to 19 Years
Eligibility Inclusion Criteria:

Diagnosed with either one of the following chronic conditions:

- Inflammatory bowel disease;

- autoimmune hepatitis;

- liver transplant;

- renal transplant;

- systemic lupus erythematosus;

- juvenile dermatomyositis;

- juvenile idiopathic arthritis.

Exclusion Criteria:

- Patients with physical limitations that preclude exercise.

- Patients diagnosed with COVID-19.

- Patients diagnosed with mental disorders.

Study Design


Intervention

Other:
Exercise training group
Online aerobic home-based exercise training, 3 times per week, during 3 months. The exercise program is composed by 3 levels (starter, intermediate and advanced) which be completed in the first, second and third month of intervention, respectively.

Locations

Country Name City State
Brazil Univsersity of Sao Paulo Sao Paulo

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Safety and efficacy of a home-based exercise training program Semi structured interview From baseline to 3 months of follow-up
Secondary Patients perceptions during social isolation Semi structured interview From baseline to 3 months of follow-up
Secondary Adolescents quality of life Quality of life will be assessed by means of Pediatric Quality of Life inventory (PedsQLTM 4.0) From baseline to 3 months of follow-up
Secondary Disease activity Will be assessed by means of a visual analog scale (from 0 - no disease activity) to 10 - maximum disease activity). From baseline to 3 months of follow-up
Secondary Disease overall assessment Will be assessed using the visual analog scale from 0 (very good condition) to 10 (very poor condition). From baseline to 3 months of follow-up
Secondary Strengths and difficulties Will be assessed by means of Strengths & Difficulties Questionnaires From baseline to 3 months of follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT06386172 - Electronic Decision-support System to Improve Detection and Care of Patients With Chronic Kidney Disease in Stockholm N/A
Recruiting NCT04910867 - APOL1 Genetic Testing Program for Living Donors N/A
Completed NCT03434145 - Changes of Ocular Structures After Hemodialysis in Patients With Chronic Kidney Diseases N/A
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Terminated NCT05022329 - COVID-19 Vaccine Boosters in Patients With CKD Phase 2/Phase 3
Not yet recruiting NCT04925661 - HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia Phase 1
Recruiting NCT04961164 - Resistant Starch Prebiotic Effects in Chronic Kidney Disease N/A
Completed NCT05015647 - Low Protein Diet in CKD Patients at Risk of Malnutrition N/A
Completed NCT03426787 - Helping Empower Liver and Kidney Patients N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Completed NCT04363554 - The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease N/A
Recruiting NCT04831021 - Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role? N/A
Terminated NCT04877847 - Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury N/A
Recruiting NCT04422652 - Combination of Novel Therapies for CKD Comorbid Depression Phase 2
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Not yet recruiting NCT06330480 - Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease N/A
Recruiting NCT03176862 - Left Ventricular Fibrosis in Chronic Kidney Disease N/A
Terminated NCT02539680 - Intestinal Phosphate Transporter Expression in CKD Patients N/A